SARS-CoV-2 specific CD8+ T cells in the nasal mucosa were found to persist 2 months after viral clearance, indicating the long-term effects of COVID-19 on immune reactions in the upper respiratory tract (Roukens et al., 2022). Here, CD8A is linked to COVID-19.